ofloxacin has been researched along with Kidney Calculi in 4 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Kidney Calculi: Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ofloxacin was used in the empirical and etiotropic therapy of patients with severe urinary tract infection." | 2.68 | [Outlook and experience in using ofloxacin in urology]. ( Derevianko, II; Kotliarova, GA; Siniukhin, VN, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doğan, HS | 1 |
| Sahin, A | 1 |
| Cetinkaya, Y | 1 |
| Akdoğan, B | 1 |
| Ozden, E | 1 |
| Kendi, S | 1 |
| Ilker, Y | 1 |
| Türkeri, LN | 1 |
| Korten, V | 1 |
| Tarcan, T | 1 |
| Akdaş, A | 1 |
| Derevianko, II | 1 |
| Kotliarova, GA | 1 |
| Siniukhin, VN | 1 |
| Fujita, K | 1 |
| Mizuno, T | 1 |
| Ushiyama, T | 1 |
| Suzuki, K | 1 |
| Hadano, S | 1 |
| Satoh, S | 1 |
| Kambayashi, T | 1 |
| Mugiya, S | 1 |
| Nakano, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neutrophil and Lymphocyte Counts and the Neutrophil-to-lymphocyte Ratio as a Predictor of Fever Following Percutaneous Nephrolithotomy in Patients Without Risk Factors[NCT03774940] | 519 participants (Actual) | Interventional | 2005-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for ofloxacin and Kidney Calculi
| Article | Year |
|---|---|
Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients.
Topics: Adult; Antibiotic Prophylaxis; Bacteriuria; Dose-Response Relationship, Drug; Drug Administration Sc | 2002 |
Antimicrobial prophylaxis in management of urinary tract stones by extracorporeal shock-wave lithotripsy: is it necessary?
Topics: Adult; Bacteriuria; Female; Humans; Incidence; Kidney Calculi; Lithotripsy; Male; Ofloxacin; Premedi | 1995 |
[Outlook and experience in using ofloxacin in urology].
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Drug Administration Schedule; Forecasting; Gra | 1996 |
Complicating risk factors for pyelonephritis after extracorporeal shock wave lithotripsy.
Topics: Adolescent; Adult; Age Distribution; Aged; Anti-Infective Agents, Urinary; Bacteriuria; Humans; Kidn | 2000 |